Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Competitive capacity of HIV-1 strains carrying M184I or Y181I drug-resistant mutations.

Chinese medical journal - 5 May 2009

Li Jue, Li Lin, Li Han-ping, Zhuang Dao-min, Liu Si-yang, Liu Yong-jian, Bao Zuo-yi, Wang Zheng, Li Jing-yun

Abstract excerpt

BACKGROUND: Virus with nucleoside reverse transcriptase inhibitors (NRTIs) or nonnucleoside reverse transcriptase inhibitors (NNRTIs) resistant mutations show different evolution tendencies when the anti-viral therapies are interrupted. Understanding the replication fitness of drug-resistant virus is important for the study of the prevalence of drug-resistance. For this purpose, we characterized the replication...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lamivudine

Share to Nevirapine

Share to Reverse Transcriptase Inhibitors

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to Virus Replication

Source

Identifiers

PMID: 19493444

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Competitive capacity of HIV-1 strains carrying M184I or Y181I drug-resistant mutations.PMID 19493444Read ↗

Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitors.Semantic proximity Read ↗

Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations.Semantic proximity Read ↗

Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.Semantic proximity Read ↗

Fitness variations and their impact on the evolution of antiretroviral drug resistance.Semantic proximity Read ↗

Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants.Semantic proximity Read ↗

In vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants.Semantic proximity Read ↗

Differential impact of resistance-associated mutations to protease inhibitors and nonnucleoside reverse transcriptase inhibitors on HIV-1 replication capacity.Semantic proximity Read ↗

Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation.Semantic proximity Read ↗

The contribution of HIV fitness to the evolution pattern of reverse transcriptase inhibitor resistance.Semantic proximity Read ↗

Evolution of drug-resistant viral populations during interruption of antiretroviral therapy.Semantic proximity Read ↗

Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients.Semantic proximity Read ↗

Development of drug resistance mutations in patients on highly active antiretroviral therapy: does competitive advantage drive evolution.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.